# Advisor Review - Advisor 2/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-29T00:24:16.068119
**Response ID:** resp_01810180cd766fd100697a99b492688197a80490caa8183a32
**Tokens:** 18805 in / 7692 out
**Response SHA256:** fb9b5f44e3411bbf

---

## 1) DATA–DESIGN ALIGNMENT (CRITICAL)

### a) Treatment timing vs. data coverage
- Treatments occur in **2022** and **2023** (Table 1).
- Data cover **survey years 2022–2024** (through CPS-FSS 2024), so **max(treatment year)=2023 ≤ max(data year)=2024**.  
No mismatch.

### b) Post-treatment observations
- For the **2023 adopter cohort (CO, MI, MN, NM)** used for identifying variation in TWFE/C-S, the dataset contains **post** survey years **2023 and 2024** (Tables 3–4).
- For **2022 adopters**, the paper correctly notes there is no clean pre period *within 2022–2024*; and it excludes them from TWFE/C-S to avoid no-within-state-variation under their binary treatment coding (Section 4.2.2).  
No “no-post” failure.

### c) Treatment definition consistency
- Table 1 cohort definitions match the regression sample definitions:
  - TWFE/C-S restrict to **2023 adopters + never-treated** (Table 3 notes; Table 4 notes).
  - DDD uses the same state restriction and expands households (Table 5 notes).
- Counts are consistent: **46 clusters = 4 treated + 42 controls** (Table 3), and **state-year cells = 46×3 = 138** (Tables 4–5).  
No internal treatment-timing contradiction detected.

## 2) REGRESSION SANITY (CRITICAL)

Checked Tables 3–6 for mechanical red flags:

- **No impossible values** (no NA/NaN/Inf; no R² anomalies reported).
- **Coefficients are in plausible ranges** for binary outcomes (e.g., 0.047, 0.021, −0.008).
- **Standard errors are plausible** and not wildly larger than coefficients (e.g., Table 3 SE=0.020 for coef 0.047; Table 5 SE=0.013 for coef −0.008).  
No regression-output sanity violations.

## 3) COMPLETENESS (CRITICAL)

- Regression tables report **standard errors** and/or **confidence intervals** and **sample sizes**:
  - Table 3: SEs + CI + N + clusters.
  - Table 4: SEs + CI + N + state-year cells + state counts.
  - Table 5: SEs + CI + N + state-year FE indicated.
- Figures and tables referenced in the shown text (Figures 1–5; Tables 1–6) appear present in the draft excerpt (including appendix figures).  
No placeholders (TBD/TODO/XXX) found in the provided material; no described-but-missing results sections detected.

## 4) INTERNAL CONSISTENCY (CRITICAL)

- Numbers cited in text match tables:
  - TWFE 4.7 pp (SE 2.0 pp; CI [0.9, 8.5]) corresponds to Table 3 (0.047; 0.020; CI [0.009, 0.085]).
  - DDD −0.8 pp (SE 1.3 pp; CI [−3.4, 1.8]) corresponds to Table 5 (−0.008; 0.013; CI [−0.034, 0.018]).
  - Randomization inference p-value 0.015 corresponds to Table 6 / Figure 3 annotation.
- Sample definitions are consistent across TWFE, C-S, and DDD (2023 cohort + never-treated).  
No contradictions that would invalidate the reported outputs.

ADVISOR VERDICT: PASS